In this video, Motley Fool health-care bureau chief Brenton Flynn takes a look at MAKO Surgical (NASDAQ: MAKO) and some recent information garnered from its 10-Q SEC filing, discussing how use of the company's surgical robots may be down this quarter as a result of the huge areas of population hit by Hurricane Sandy. The filing also discloses one area where MAKO's profit margins are expanding extremely quickly. For more details, follow along in the video below.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/15/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.